Answers are grounded in this paper and cite their sources.
Background Early detection of intestinal fibrosis in Crohn’s disease (CD) remains challenging. Glycolytic reprogramming is associated with early fibrotic remodelling but cannot be detected by conventional imaging; phosphorus-31 magnetic resonance spectroscopy (31P-MRS) enables non-invasive measurement of such metabolic alterations. Objective To establish intestinal 31P-MRS feasibility, correlate its metabolic parameters with glycolytic reprogramming and CD fibrosis and develop a metabolic strategy for fibrosis stratification. Design This prospective study enrolled 121 CD participants who underwent MR enterography, magnetisation transfer imaging and 31P-MRS alongside 21 healthy volunteers (31P-MRS only). Intestinal 31P-MRS spectrum was assigned via phantom experiment; phosphocreatine (PCr)/total phosphorus (TP) and potential of hydrogen (pH) were biochemically validated. 31P-MRS parameters were correlated with histological glycolytic reprogramming markers (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), hexokinase 2 (HK2), lactate, succinate dehydrogenase complex iron sulfur subunit B (SDHB)) and fibrosis severity. Three diagnostic strategies (PCr/ATP-only, pH-only and PCr/ATP and pH combination) were derived and internally validated. Results Intestinal 31P-MRS-derived metabolite ratios and pH were reliably measured. 31P-MRS-derived PCr/TP correlated positively with ex vivo PCr (r=0.44, p=0.02); pH inversely with tissue lactate (r=−0.71, p<0.001). Histological glycolytic reprogramming correlated with fibrosis severity: PFKFB3, HK2 and lactate correlated positively (r=0.45 to 0.75, all p≤0.02) and SDHB inversely (r=−0.50 to −0.49, both p=0.01). 31P-MRS-derived PCr/ATP correlated with glycolytic markers (r=−0.59 to 0.43) and pH with lactate (r=−0.71); both correlated with fibrosis severity (r=−0.75 to −0.57, all p≤0.01). Combined strategy outperformed single parameters, with 80.70% accuracy for onset of fibrosis detection and 82.61% for moderate-to-severe fibrosis evaluation in derivation cohort, and 90.59% and 85.33% in internal test cohort, respectively. Conclusion Intestinal 31P-MRS is feasible in CD, with PCr/ATP and pH correlating with glycolytic reprogramming and fibrosis severity. Thus, combined PCr/ATP and pH strategy enables accurate stratification of intestinal fibrosis.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: